Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Arlidin
2. Bufenine
3. Buphenin
4. Buphenine
5. Dilatol
6. Hydrochloride, Nylidrin
7. Nylidrin
1. 849-55-8
2. Buphenine Hydrochloride
3. Nylidrin (hydrochloride)
4. Nylidrin Hcl
5. Arlibide
6. Arlidin
7. Buphedrin
8. Dilatol
9. Vasiten
10. Buphenin Hydrochloride
11. Nsc-142004
12. Mls000069387
13. Dilatyl
14. Suprifen Psb Hydrochloride
15. 4-[1-hydroxy-2-(4-phenylbutan-2-ylamino)propyl]phenol;hydrochloride
16. Smr000058488
17. Nylidrin Hydrochloride (jan)
18. Ec69e3pw7e
19. Nylidrin Hydrochloride [jan]
20. Sr-01000002981
21. Buphenine Hcl
22. P-hydroxy-.alpha.-[1-[(1-methyl-3-phenylpropyl)amino]ethyl]benzyl Alcohol Hydrochloride
23. P-hydroxy-.alpha.-(1-((1-methyl-3-phenylpropyl)amino)ethyl)benzyl Alcohol Hydrochloride
24. Arlidin (tn)
25. Nylidrine Hydrochloride
26. Opera_id_1722
27. Mls001076116
28. Schembl364078
29. Spectrum1500445
30. Chembl1204337
31. Chebi:31925
32. Dtxsid20957360
33. Hms1920d06
34. Pharmakon1600-01500445
35. Nylidrin Hydrochloride [mi]
36. Amy23363
37. Hy-b1404
38. Tox21_500911
39. Ccg-40183
40. Mfcd00035085
41. Nsc142004
42. Nsc757252
43. S5267
44. Nylidrin Hydrochloride [vandf]
45. Wln: Qr Dyqy1&my1&2r &gh
46. Akos030242878
47. Buphenine Hydrochloride [mart.]
48. Cs-4980
49. Lp00911
50. Nsc-757252
51. Buphenine Hydrochloride [who-dd]
52. Ncgc00094222-01
53. Ncgc00094222-02
54. Ncgc00094222-03
55. Ncgc00094222-04
56. Ncgc00261596-01
57. As-19644
58. Eu-0100911
59. Ft-0757340
60. N-153
61. D01543
62. A923155
63. Q9668243
64. Sr-01000002981-2
65. 4-(1-hydroxy-2-(4-phenylbutan-2-ylamino)propyl)phenol Hydrochloride
66. 1-p-hydroxyphenyl-2-[(1'-methyl-3'-phenylpropyl)amino]-1-propanol Hydrochloride
67. 4-{1-hydroxy-2-[(4-phenyl-2-butanyl)amino]propyl}phenol Hydrochloride (1:1)
68. 900-01-6
69. Benzenemethanol, 4-hydroxy-.alpha.-(1-((1-methyl-3-phenylpropyl)amino)ethyl)-, Hydrochloride
| Molecular Weight | 335.9 g/mol |
|---|---|
| Molecular Formula | C19H26ClNO2 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 7 |
| Exact Mass | 335.1652068 g/mol |
| Monoisotopic Mass | 335.1652068 g/mol |
| Topological Polar Surface Area | 52.5 Ų |
| Heavy Atom Count | 23 |
| Formal Charge | 0 |
| Complexity | 296 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 3 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Sympathomimetics
Drugs that mimic the effects of stimulating postganglionic adrenergic sympathetic nerves. Included here are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters. (See all compounds classified as Sympathomimetics.)
Vasodilator Agents
Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)
Adrenergic beta-Agonists
Drugs that selectively bind to and activate beta-adrenergic receptors. (See all compounds classified as Adrenergic beta-Agonists.)
Tocolytic Agents
Drugs that prevent preterm labor and immature birth by suppressing uterine contractions (TOCOLYSIS). Agents used to delay premature uterine activity include magnesium sulfate, beta-mimetics, oxytocin antagonists, calcium channel inhibitors, and adrenergic beta-receptor agonists. The use of intravenous alcohol as a tocolytic is now obsolete. (See all compounds classified as Tocolytic Agents.)
INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE
A Buphenine hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Buphenine hydrochloride, including repackagers and relabelers. The FDA regulates Buphenine hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Buphenine hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Buphenine hydrochloride supplier is an individual or a company that provides Buphenine hydrochloride active pharmaceutical ingredient (API) or Buphenine hydrochloride finished formulations upon request. The Buphenine hydrochloride suppliers may include Buphenine hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Buphenine hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Buphenine hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Buphenine hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Buphenine hydrochloride DMFs exist exist since differing nations have different regulations, such as Buphenine hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Buphenine hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Buphenine hydrochloride USDMF includes data on Buphenine hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Buphenine hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Buphenine hydrochloride suppliers with USDMF on PharmaCompass.
Buphenine hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Buphenine hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Buphenine hydrochloride GMP manufacturer or Buphenine hydrochloride GMP API supplier for your needs.
A Buphenine hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Buphenine hydrochloride's compliance with Buphenine hydrochloride specifications and serves as a tool for batch-level quality control.
Buphenine hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Buphenine hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Buphenine hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Buphenine hydrochloride EP), Buphenine hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Buphenine hydrochloride USP).
LOOKING FOR A SUPPLIER?
